Sign Out
One mL contains 10 mg ranibizumab.
Each vial contains 2.3 mg of ranibizumab in 0.23 mL solution.
Ranibizumab is a humanized monoclonal antibody fragment produced in Escherichia coli cells by recombinant DNA technology.
Excipients/Inactive Ingredients: alpha, alpha-trehalose dihydrate, histidine hydrochloride, monohydrate, histidine, polysorbate 20, water for injections.
